Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

This bill allows pharmacists to substitute a generic epinephrine auto-injector (like EpiPen alternatives) for a brand-name version when prescribed, under specific conditions. It directly affects patients needing epinephrine for allergies, pharmacists dispensing the devices, and prescribers writing the prescriptions. Key provisions require the generic to be cheaper, the prescriber not to prohibit substitution, the pharmacist to obtain patient consent, and to provide counseling on proper use. The law aims to increase access to affordable emergency allergy treatment without requiring additional prescription changes. It does not alter existing prescription requirements but streamlines substitution for cost-effective options.